Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matti Annala

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
British Journal of Cancer|July 11, 2018
Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastasesHeini M L Kallio, Reija Hieta, Leena Latonen, et al.
Clinical Genitourinary Cancer|February 13, 2020
Plasma Circulating Tumor DNA and Clonal Hematopoiesis in Metastatic Renal Cell CarcinomaJack V W Bacon, Matti Annala, Maryam Soleimani, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2012
Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB networkKristen M Holmes, Matti Annala, Corrine Y X Chua, et al.
Lab on a Chip|May 16, 2018
Isolation and genome sequencing of individual circulating tumor cells using hydrogel encapsulation and laser capture microdissectionEmily S Park, Justin P Yan, Richard A Ang, et al.
European Urology Oncology|December 13, 2021
Somatic Features of Response and Relapse in Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin ImmunotherapyJack V W Bacon, David C Müller, Elie Ritch, et al.
Cancer Research|August 19, 2015
Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate CancerAntti Ylipää, Kati Kivinummi, Annika Kohvakka, et al.
Scientific Reports|August 18, 2022
PTPRD and CNTNAP2 as markers of tumor aggressiveness in oligodendrogliomasKirsi J Rautajoki, Serafiina Jaatinen, Aliisa M Tiihonen, et al.
Nature Biotechnology|January 29, 2013
Evaluation of methods for modeling transcription factor sequence specificityMatthew T Weirauch, Atina Cote, Raquel Norel, et al.
Urologic Oncology|July 31, 2019
Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancerVera Genitsch, Attila Kollár, Gillian Vandekerkhove, et al.
Urologic Oncology|October 6, 2019
Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancerVera Genitsch, Attila Kollár, Gillian Vandekerkhove, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|July 11, 2018
Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastasesHeini M L Kallio, Reija Hieta, Leena Latonen, et al.
Clinical Genitourinary Cancer|February 13, 2020
Plasma Circulating Tumor DNA and Clonal Hematopoiesis in Metastatic Renal Cell CarcinomaJack V W Bacon, Matti Annala, Maryam Soleimani, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2012
Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB networkKristen M Holmes, Matti Annala, Corrine Y X Chua, et al.
Lab on a Chip|May 16, 2018
Isolation and genome sequencing of individual circulating tumor cells using hydrogel encapsulation and laser capture microdissectionEmily S Park, Justin P Yan, Richard A Ang, et al.
European Urology Oncology|December 13, 2021
Somatic Features of Response and Relapse in Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin ImmunotherapyJack V W Bacon, David C Müller, Elie Ritch, et al.
Cancer Research|August 19, 2015
Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate CancerAntti Ylipää, Kati Kivinummi, Annika Kohvakka, et al.
Scientific Reports|August 18, 2022
PTPRD and CNTNAP2 as markers of tumor aggressiveness in oligodendrogliomasKirsi J Rautajoki, Serafiina Jaatinen, Aliisa M Tiihonen, et al.
Nature Biotechnology|January 29, 2013
Evaluation of methods for modeling transcription factor sequence specificityMatthew T Weirauch, Atina Cote, Raquel Norel, et al.
Urologic Oncology|July 31, 2019
Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancerVera Genitsch, Attila Kollár, Gillian Vandekerkhove, et al.
Urologic Oncology|October 6, 2019
Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancerVera Genitsch, Attila Kollár, Gillian Vandekerkhove, et al.
Pageof 7